Kraig Biocraft Laboratories Free Cash Flow (FCF) History (KBLB)

Kraig Biocraft Laboratories reported −$1.8M in free cash flow for fiscal 2025, an increase of $48,961 from the previous fiscal year.

View full Kraig Biocraft Laboratories company overview

Kraig Biocraft Laboratories free cash flow by year

Kraig Biocraft Laboratories annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$1.8M$48,961——
20242024-12-31−$1.8M−$592,444——
20232023-12-31−$1.3M$641,326——
20222022-12-31−$1.9M$5,755——
20212021-12-31−$1.9M———
20192019-12-31−$1.2M−$942,217——
20182018-12-31−$246,453$514,256—−61.36%
20172017-12-31−$760,709$253,620—−781.67%
20162016-12-31−$1.0M−$7,481—−3183.91%
20152015-12-31−$1.0M−$60,484——
20142014-12-31−$946,364−$142,737——
20132013-12-31−$803,627−$240,705——
20122012-12-31−$562,922−$5,652——
20112011-12-31−$557,270−$335,080——
20102010-12-31−$222,190———

Kraig Biocraft Laboratories free cash flow growth trends

Kraig Biocraft Laboratories's latest reported quarter, Q2 2026, generated −$627,303 in free cash flow.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Kraig Biocraft Laboratories source filings ↗

Community posts

It’s quiet here.

No posts about KBLB yet. Start the conversation.

Write the first post